Scottish Dental Clinical Effectiveness Programme

Other public bodies · Sub-organisation

Pin Request correction

First report 24 Apr 2024•Latest report 24 Apr 2024

Reports, concerns and published responses

Reports over time

Reports naming this recipient by issue year.

* 2026 is projected from reports observed to 7 Sep 2026.

Reports
1

Naming this recipient

Published responses
0%

Found for named reports

Concerns addressed
0

Across all linked responses

Stated actions
0

Described in responses

Concerns and recipient responses

Statements from Scottish Dental Clinical Effectiveness Programme linked to the concerns in each report. Select any concern, action or position to view the source wording.

  1. Derby and Derbyshire

    AI-generated summary

    Derek HAND · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Derek HAND experienced continued bleeding after a tooth extraction while taking Clopidogrel, lost consciousness, and was admitted to hospital. Although his condition initially improved, he later developed swallowing difficulties and aspiration pneumonia, deteriorated, and died on end-of-life care. The principal concern was whether current guidance should require blood testing before dental procedures for patients taking Clopidogrel to identify a risk of excess bleeding.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below. The report was sent to Scottish Dental Clinical Effectiveness Programme; that does not assign responsibility.

    PFD Monitor interpretation

    Failure to require clotting-function checks for patients taking Clopidogrel before dental procedures

    Wider context from the report

    “The NHS Education for Scotland Management of Dental Patients Taking Anticoagulants or Antiplatelet Drugs states that for patients on Clopidogrel dental treatment can occur without interrupting medication. This is in contrast to, for example, patients on Warfarin, who are required to have an INR test prior to any procedure. Mr Hand's tooth extraction was performed as per the current guidance. As he was on Clopidogrel the procedure was carried out with no further checks being carried out as to his clotting function. Following the tooth extraction the site continued to bleed, to the extent that Mr Hand lost consciousness, required hospital admission and subsequently developed aspiration pneumonia. My concern is that as the current guidance does not require any further checks for patients on Clopidogrel prior to dental procedures there is a risk of other patients on Clopidogrel experiencing excess bleeding following dental procedures. It would be of assistance to know whether: a. Has any thought been given to requiring an INR test or any other form of blood test to detect a risk of excess bleeding for patients on Clopidogrel prior to dental procedures? b. If it has not, is there a reason for this? ”
    Open source report
Back to top

Information checked against published PFD reports and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Data last updated 7 September 2026